Skip to main content
  • AACR Publications
    • Blood Cancer Discovery
    • Cancer Discovery
    • Cancer Epidemiology, Biomarkers & Prevention
    • Cancer Immunology Research
    • Cancer Prevention Research
    • Cancer Research
    • Clinical Cancer Research
    • Molecular Cancer Research
    • Molecular Cancer Therapeutics

AACR logo

  • Register
  • Log in
  • My Cart
Advertisement

Main menu

  • Home
  • About
    • The Journal
    • AACR Journals
    • Subscriptions
    • Permissions and Reprints
    • Reviewing
  • Articles
    • OnlineFirst
    • Current Issue
    • Past Issues
    • Meeting Abstracts
    • Collections
      • COVID-19 & Cancer Resource Center
      • Focus on Computer Resources
      • Highly Cited Collection
      • Editors' Picks
      • "Best of" Collection
  • For Authors
    • Information for Authors
    • Author Services
    • Early Career Award
    • Best of: Author Profiles
    • Submit
  • Alerts
    • Table of Contents
    • Editors' Picks
    • OnlineFirst
    • Citations
    • Author/Keyword
    • RSS Feeds
    • My Alert Summary & Preferences
  • News
    • Cancer Discovery News
  • COVID-19
  • Webinars
  • Search More

    Advanced Search

  • AACR Publications
    • Blood Cancer Discovery
    • Cancer Discovery
    • Cancer Epidemiology, Biomarkers & Prevention
    • Cancer Immunology Research
    • Cancer Prevention Research
    • Cancer Research
    • Clinical Cancer Research
    • Molecular Cancer Research
    • Molecular Cancer Therapeutics

User menu

  • Register
  • Log in
  • My Cart

Search

  • Advanced search
Cancer Research
Cancer Research
  • Home
  • About
    • The Journal
    • AACR Journals
    • Subscriptions
    • Permissions and Reprints
    • Reviewing
  • Articles
    • OnlineFirst
    • Current Issue
    • Past Issues
    • Meeting Abstracts
    • Collections
      • COVID-19 & Cancer Resource Center
      • Focus on Computer Resources
      • Highly Cited Collection
      • Editors' Picks
      • "Best of" Collection
  • For Authors
    • Information for Authors
    • Author Services
    • Early Career Award
    • Best of: Author Profiles
    • Submit
  • Alerts
    • Table of Contents
    • Editors' Picks
    • OnlineFirst
    • Citations
    • Author/Keyword
    • RSS Feeds
    • My Alert Summary & Preferences
  • News
    • Cancer Discovery News
  • COVID-19
  • Webinars
  • Search More

    Advanced Search

Advances in Brief

“Loop” Domain Is Necessary for Taxol-induced Mobility Shift and Phosphorylation of Bcl-2 as Well as for Inhibiting Taxol-induced Cytosolic Accumulation of Cytochrome c and Apoptosis

Guofu Fang, Brian S. Chang, Caryn N. Kim, Charles Perkins, Craig B. Thompson and Kapil N. Bhalla
Guofu Fang
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Brian S. Chang
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Caryn N. Kim
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Charles Perkins
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Craig B. Thompson
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Kapil N. Bhalla
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
DOI:  Published August 1998
  • Article
  • Info & Metrics
  • PDF
Loading

Abstract

Taxol, 1-β-d-arabinofuranosylcytosine (ara-C), and etoposide induce apoptosis in HL-60 cells that is blocked by overexpression of Bcl-2 or Bcl-xl. A ∼60-amino acid “loop” domain of Bcl-2 and Bcl-xl that contains phosphorylation sites is known to negatively regulate their antiapoptotic function. In the present studies, Taxol-, ara-C-, or etoposide-induced apoptosis was examined in HL-60/Bcl-2Δ and HL-60/Bcl-xlΔ cells that express the loop-deletional mutant cDNA constructs p19Bcl-2Δ32-80 and p18Bcl-xlΔ26–83, respectively. This was compared with control HL-60/neo cells as well as HL-60/Bcl-2 and HL-60/Bcl-xl cells. The latter two cell lines overexpress full-length Bcl-2 and Bcl-xl, respectively. Immunoblot analyses showed that HL-60/neo and HL-60/Bcl-2Δ cells express similar levels of p26Bcl-2. In contrast, as compared with HL-60/neo, HL-60/Bcl-xlΔ cells expressed significantly lower levels of p26Bcl-2. p29Bcl-xl and p21Bax levels were similar in all cell types. Exposure to etoposide (50 µm) or ara-C (100 µm) for 4 h induced apoptosis in HL-60/neo cells, but not in HL-60/Bcl-2, HL-60/Bcl-xl, HL-60/Bcl-2Δ, or HL-60/Bcl-xlΔ cells. In contrast, Taxol treatment (500 nm for 24 h) triggered the molecular cascade of apoptosis, represented by the cytosolic increase of cytochrome c and poly(ADP-ribose) polymerase or the DNA fragmentation factor cleavage activity of caspase-3 in HL-60/neo cells as well as in HL-60/Bcl-xlΔ and HL-60/Bcl-2Δ cells, but not in their counterparts overexpressing full-length Bcl-2 and Bcl-xl. Equal amounts of p26Bcl-2 were coimmunoprecipitated with apoptosis protease-activating factor 1 (APAF-1) in HL-60/neo and HL-60/Bcl-2Δ cells, whereas a markedly higher level of p26Bcl-2 coimmunoprecipitated with APAF-1 in HL-60/Bcl-2 cells. In association with Taxol-induced apoptosis, the levels of Bcl-2 that were coimmunoprecipitated with APAF-1 declined in HL-60/neo and HL-60/Bcl-2Δ cells. This was not observed in HL-60/Bcl-2 cells, in which Taxol-induced apoptosis was blocked. Previous studies have demonstrated that Taxol induces phosphorylation of Bcl-2 in association with Taxol-induced apoptosis of HL-60/neo cells. Immunoblot analysis demonstrated a Taxol-induced mobility shift of Bcl-2 but not p19Bcl-2Δ. Taxol also increased [32P]Pi incorporation in p26Bcl-2, but not in p19Bcl-2Δ or p18Bcl-xl. These findings indicate that the loop domain is necessary for the Taxol-induced mobility shift and phosphorylation of Bcl-2. Loop domain also seems to be necessary for the antiapoptotic effect of Bcl-2 against Taxol-induced apoptosis but not ara-C- or etoposide-induced apoptosis.

Footnotes

  • ↵1 To whom requests for reprints should be addressed, at Division of Hematology/Oncology, Department of Medicine, Winship Cancer Center, Emory University School of Medicine, 1365-B Clifton Road N.E., Atlanta, GA 30322. Phone: (404) 778-3992; Fax (404) 778-3965.

  • Received January 19, 1998.
  • Accepted June 9, 1998.
  • ©1998 American Association for Cancer Research.
PreviousNext
Back to top
August 1998
Volume 58, Issue 15
  • Table of Contents
  • Table of Contents (PDF)
  • Back Matter (PDF)
  • Editorial Board (PDF)
  • Front Matter (PDF)

Sign up for alerts

Open full page PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for sharing this Cancer Research article.

NOTE: We request your email address only to inform the recipient that it was you who recommended this article, and that it is not junk mail. We do not retain these email addresses.

Enter multiple addresses on separate lines or separate them with commas.
“Loop” Domain Is Necessary for Taxol-induced Mobility Shift and Phosphorylation of Bcl-2 as Well as for Inhibiting Taxol-induced Cytosolic Accumulation of Cytochrome c and Apoptosis
(Your Name) has forwarded a page to you from Cancer Research
(Your Name) thought you would be interested in this article in Cancer Research.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
“Loop” Domain Is Necessary for Taxol-induced Mobility Shift and Phosphorylation of Bcl-2 as Well as for Inhibiting Taxol-induced Cytosolic Accumulation of Cytochrome c and Apoptosis
Guofu Fang, Brian S. Chang, Caryn N. Kim, Charles Perkins, Craig B. Thompson and Kapil N. Bhalla
Cancer Res August 1 1998 (58) (15) 3202-3208;

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
“Loop” Domain Is Necessary for Taxol-induced Mobility Shift and Phosphorylation of Bcl-2 as Well as for Inhibiting Taxol-induced Cytosolic Accumulation of Cytochrome c and Apoptosis
Guofu Fang, Brian S. Chang, Caryn N. Kim, Charles Perkins, Craig B. Thompson and Kapil N. Bhalla
Cancer Res August 1 1998 (58) (15) 3202-3208;
del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
  • Info & Metrics
  • PDF
Advertisement

Related Articles

Cited By...

More in this TOC Section

Advances in Brief

  • Activating Mutations of the Noonan Syndrome-Associated SHP2/PTPN11 Gene in Human Solid Tumors and Adult Acute Myelogenous Leukemia
  • Recombinant Listeria Vaccines Containing PEST Sequences Are Potent Immune Adjuvants for the Tumor-Associated Antigen Human Papillomavirus-16 E7
  • Granulocyte-Macrophage Colony-Stimulating Factor and Interleukin-2 Fusion cDNA for Cancer Gene Immunotherapy
Show more Advances in Brief

Articles

  • Intersections between Blood Cell Development and Leukemia Genes
  • BCL-2 Gene Family and the Regulation of Programmed Cell Death
  • Core-Binding Factor: A Central Player in Hematopoiesis and Leukemia
Show more Articles
  • Home
  • Alerts
  • Feedback
  • Privacy Policy
Facebook  Twitter  LinkedIn  YouTube  RSS

Articles

  • Online First
  • Current Issue
  • Past Issues
  • Meeting Abstracts

Info for

  • Authors
  • Subscribers
  • Advertisers
  • Librarians

About Cancer Research

  • About the Journal
  • Editorial Board
  • Permissions
  • Submit a Manuscript
AACR logo

Copyright © 2021 by the American Association for Cancer Research.

Cancer Research Online ISSN: 1538-7445
Cancer Research Print ISSN: 0008-5472
Journal of Cancer Research ISSN: 0099-7013
American Journal of Cancer ISSN: 0099-7374

Advertisement